Labopharm Inc. (CAN) (NASDAQ:DDSS) Is Today’s Most Active Stock

Those investors who are planning to make money in the penny stock market should subscribe to FREE Alerts by visiting: http://www.pennystockpickreport.com/
 

After yesterday’s rally of over 38% shares of Labopharm Inc. (CAN) (NASDAQ:DDSS) are again trading higher by 13% to $2.14 on huge volume of 1.40 million shares. Yesterday, the company said manufacturing issues for its once-daily Trazodone drug have been settled, paving the way for U.S. approval early next year. As reported, Labopharm said the maker of the active pharmaceutical ingredient, Angelini of Italy, received a letter from the U.S. Food and Drug Administration stating that deficiencies found during inspections earlier this year have been “appropriately addressed” and the facility is “acceptable.”


The stock has a 52-week range of $0.32-$2.95. So far this year the stock has jumped up over 57%.


Labopharm Inc. is an international specialty pharmaceutical company focused on improving existing drugs by incorporating its advanced controlled-release technologies. The Company develops products internally in order to enter into strategic alliances or licensing agreements with national or international pharmaceutical companies that have the necessary resources and distribution networks to market and sell its pharmaceutical products.

ABOUT PennyStockPickReport.com

www.pennystockpickreport.com is one of the leading stock web site that provides free stock newsletters and alerts and tracks small cap penny stocks that could be on the brink of a massive breakout.  If you wish to get your company featured on our website then please contact us at info @PennyStockPickReport.com